Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
OBJECTIVES: The use of clinical staging in the fatal neurodegenerative disease amyotrophic lateral sclerosis would have value in optimising future therapeutic trials. We aimed to use previous clinical trial data to determine the length of time patients spend in each of four proposed stages, its rang...
Auteurs principaux: | Balendra, R, Jones, A, Jivraj, N, Steen, I, Young, C, Shaw, P, Turner, M, Leigh, P, Al-Chalabi, A |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2015
|
Documents similaires
-
Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
par: Balendra, R, et autres
Publié: (2015) -
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
par: Jones, A, et autres
Publié: (2014) -
Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
par: Balendra, R, et autres
Publié: (2014) -
Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
par: Jones, A, et autres
Publié: (2013) -
Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System
par: Balendra, R, et autres
Publié: (2013)